Innate Pharma SA (IPHA) stock
IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
$1.03−0.30 (-22.56%)
Close on Nov 18, 2026Market cap $96.53MP/E –Yield –
Innate Pharma shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 90M, up 10.5% from the year before. The highest annual figure on record is 90M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90M | +10.5% |
| FY2024 | Dec 31, 2024 | 81M | +0.7% |
| FY2023 | Dec 31, 2023 | 80M | +1.0% |
| FY2022 | Dec 31, 2022 | 80M | +0.1% |
| FY2021 | Dec 31, 2021 | 80M | +0.8% |
| FY2020 | Dec 31, 2020 | 79M | +18.0% |
| FY2019 | Dec 31, 2019 | 67M | +13.8% |
| FY2018 | Dec 31, 2018 | 59M | +8.1% |
| FY2017 | Dec 31, 2017 | 54M | – |
See a number that looks wrong?